The management of metastatic renal cell carcinoma.
D000230:Adenocarcinoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D011374:Progesterone / Q000627:therapeutic use; D011379:Prognosis; D013739:Testosterone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013739:Testosterone; D011374:Progesterone; D008525:Medroxyprogesterone